Recs

12

An Unwavering Approach at UnitedHealth Group

In the company's third-quarter earnings call on Thursday, UnitedHealth Group (NYSE: UNH  ) President and CEO Stephen Hemsley noted that the company continued to maintain its disciplined pricing approach "across the commercial benefits market even at the cost of membership growth."

I can definitely respect his approach in this instance, and I believe it is in the company's best interests in the long run. Enrollment is down slightly since June, but with the bulk of the decreased enrollment numbers coming from the company's risk-based business, shareholders should not be overly concerned.

This disciplined pricing approach has not only enabled the company to improve its operating margin by 110 basis points on a year-over-year basis, but it has also brought about a 160-basis-point improvement in the insurer's medical care ratio compared to its year-ago quarter.

Overall, business continues strong, with diluted third-quarter EPS increasing 19% on a 4% rise in total revenue. The lackluster performance of UnitedHealth's stock also gave the company a compelling reason to repurchase $2 billion of its common stock during the quarter. It also announced intentions to buy back an additional $7 billion by the end of UnitedHealth's fiscal year in 2008.

As for UnitedHealth's competition, results have been mixed thus far in 2007. Aetna (NYSE: AET  ) is up an impressive 23% year to date, and Cigna (NYSE: CI  ) is up 16.0% over the same time. WellPoint (NYSE: WLP  ) , on the other hand, has lagged the market, with its current stock price about the same as it was at the beginning of the year.

For investors with the patience to ride out the current lull in UnitedHealth's stock price, better days should be ahead, thanks to the approach the company's management team has implemented.

For related Foolishness, check out:

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 538904, ~/Articles/ArticleHandler.aspx, 2/15/2012 2:01:42 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 hours ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,350.50 -1.27 -0.09%
NASD 2,931.83 0.44 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 4:06 PM
UNH $54.46 Up +0.61 +1.13%
UnitedHealth Group CAPS Rating: *****
WLP $65.69 Up +1.03 +1.59%
WellPoint, Inc. CAPS Rating: *****
CI $43.99 Up +0.81 +1.88%
Cigna Corporation CAPS Rating: ***
AET $47.27 Up +1.01 +2.18%
Aetna, Inc. CAPS Rating: ****

Advertisement